Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1021036.RA-GcPyLa2RjW3PrWyrmIAHNJ1plMV17_Vj7CUcAvqYyQ130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1021036.RA-GcPyLa2RjW3PrWyrmIAHNJ1plMV17_Vj7CUcAvqYyQ130_assertion type Assertion NP1021036.RA-GcPyLa2RjW3PrWyrmIAHNJ1plMV17_Vj7CUcAvqYyQ130_head.
- NP1021036.RA-GcPyLa2RjW3PrWyrmIAHNJ1plMV17_Vj7CUcAvqYyQ130_assertion description "[Prognostic significance of NSE mRNA in advanced NSCLC treated with gefitinib.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1021036.RA-GcPyLa2RjW3PrWyrmIAHNJ1plMV17_Vj7CUcAvqYyQ130_provenance.
- NP1021036.RA-GcPyLa2RjW3PrWyrmIAHNJ1plMV17_Vj7CUcAvqYyQ130_assertion evidence source_evidence_literature NP1021036.RA-GcPyLa2RjW3PrWyrmIAHNJ1plMV17_Vj7CUcAvqYyQ130_provenance.
- NP1021036.RA-GcPyLa2RjW3PrWyrmIAHNJ1plMV17_Vj7CUcAvqYyQ130_assertion SIO_000772 23065601 NP1021036.RA-GcPyLa2RjW3PrWyrmIAHNJ1plMV17_Vj7CUcAvqYyQ130_provenance.
- NP1021036.RA-GcPyLa2RjW3PrWyrmIAHNJ1plMV17_Vj7CUcAvqYyQ130_assertion wasDerivedFrom befree-2016 NP1021036.RA-GcPyLa2RjW3PrWyrmIAHNJ1plMV17_Vj7CUcAvqYyQ130_provenance.
- NP1021036.RA-GcPyLa2RjW3PrWyrmIAHNJ1plMV17_Vj7CUcAvqYyQ130_assertion wasGeneratedBy ECO_0000203 NP1021036.RA-GcPyLa2RjW3PrWyrmIAHNJ1plMV17_Vj7CUcAvqYyQ130_provenance.